Honokiol inhibits melanoma stem cells by targeting notch signaling
2014 · Molecular Carcinogenesis · 76 citations
https://doi.org/10.1002/mc.22242
D
David Standing
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
788
Citations
13
h-index
14
i10-index
David Standing is an academic researcher from The University of Kansas Cancer Center. The author has contributed to research in topics: Cancer Cells and Metastasis & Pancreatic and Hepatic Oncology Research & Cancer-related molecular mechanisms research. The author has an h-index of 13, co-authored 31 publications.
ORCID: 0000-0003-3153-4374Papers by this author
worksCucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway
2020 · Scientific Reports · 75 citations
https://doi.org/10.1038/s41598-020-57940-9
Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex
2021 · Cell Death and Disease · 13 citations
https://doi.org/10.1038/s41419-021-03836-z
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer
2024 · Cell Death and Disease · 2 citations
https://doi.org/10.1038/s41419-024-06717-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat